Leading Experts Discussed Clinical Results and Cost Effectiveness of Intraoperative Detection of Cancer on the Tissue Margin During Lumpectomy for Breast Cancer

[vc_row][vc_column][vc_column_text]Leading experts discussed clinical results and cost effectiveness of intra-operative detection of cancer on the tissue margin during lumpectomy for breast cancer—Vienna, Austria, March 22, 2012- Dilon Devices, the manufacturer of the MarginProbe® System, held a satellite symposium featuring discussions with experts in the field of breast cancer regarding the treatment of women with early…

Read More

Dune’s MarginProbe® Approved by Israel’s Largest HMO

[vc_row][vc_column][vc_column_text]4 Million Covered Lives Provided Access to MarginProbe Caesarea, Israel, March 12, 2012. Dilon announced today that Clalit, Israel’s largest HMO, with a network of 8 surgical centers and 4 million insured, has informed Dilon that it has approved the MarginProbe System for use throughout the Clalit network. The MarginProbe System provides surgeons the ability…

Read More